Monthly Archives: November 2009

Q&A With Renee Tannenbaum

One major theme at the HBA leadership conference may be simple for industry to understand but difficult to accept: change or drown. But for Renee Tannenbaum, it was change that worked toward her advantage. And change, combined with her desire to drive improvement in patient care and meet unmet needs, is what led her to […]
Posted in Events, Strategy | Tagged , , , , , , , , | Leave a comment

Hot Topics at HBA

The 2009 Healthcare Businesswomen’s Association leadership conference is officially underway in sunny California. Last night, festivities got underway with a welcome reception for attendees followed by a “Taste of San Francisco,” which featured lively entertainment and regional cuisine. I had the opportunity to catch up with a few seasoned participants who are widely known throughout […]
Posted in Events | Tagged , , , | 1 Comment

Past Performance Is No Indication Of Future Results

Sponsored Guest blog post by Patrick Homer, Life Science Practice Principal, SAS. The lingo that accompanies every financial investment prospectus has never been more apt in our post meltdown economy. Yet when it comes down to directing the billion dollar investments in sales and marketing spends, the pharma industry has been firmly entrenched in this […]
Posted in Guest Blog, Strategy | Tagged , , , , , , , | Leave a comment

When Big Pharma Leaves Town

Image via Wikipedia Wall Street smiles when a drug company gets with the program by “restructuring” and “rightsizing”—cutting costs through headline-grabbing layoffs. But for Main Street, the story of hundreds or thousands of sales reps, say, and researchers getting kicked to the curb is quite different. The two gi-normous mergers that closed in the past […]
Posted in Strategy | Tagged , , , , , , , | 2 Comments

Google Unveils New Pharma Ads

Image via CrunchBase Google just showed off mockups of its fancy new pharma ads at FDA’s social media hearing, on November 12. A few months back, the big G mentioned that it was working on ads to appease both pharmaceutical marketers and FDA, but this is the first time most people got to lay eyes […]
Posted in Strategy | Tagged , , , , , , , | 2 Comments
  • Categories

  • Meta